4-([1,2,4]TRIAZOLO[1,5-A]PYRIDIN-7-YLOXY)-3-METHYLANILINE, 95%, 5g

Tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate, 98%, 5g

Imidazo[1,2-a]pyrazine-3-carboxylic acid, 95.0%, 1g

Ethyl 2-bromooxazole-4-carboxylate, 95.0%, 250mg

(R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid, 98.0%, 1g

1,4-Butylenediphosphonic Acid>98.0%(T)1g

1,4-Anhydro-D-glucitol, 95%, 250mg

4-Chloro-7-methoxyquinoline-6-carbonitrile, 98%, 5g

1-CARBETHOXYIMIDAZOLE, 95.0%, 25g

GC capillary column ROTI®Cap-1, 25 m, 0.53 mm, 1.00 µm, 1 Piece(s)

4-Bromo-4'-butyl-1,1'-biphenyl, 95.0%, 5g

2-Chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 98%, 500mg

Lead(IV) oxide, min. 97%, pa, 100 g, plastic packaging.